Guildford, UK (OBBeC)  - IDBS has unveiled that the Australian pharmaceutical company, Cancer Therapeutics CRC (CTx, Melbourne, Australia), has selected both E-WorkBook and ActivityBase to manage its drug discovery and development on a global multi-site basis.

Consisting of 11 different organizations collaborating in cancer therapeutics research, CTx works closely with leading Australian researchers and institutes to discover, protect and develop small molecule discoveries into preclinical drug candidates with commercial potential.

According to the announcement, CTx chose ActivityBase because of positive user experience of the product at other participant CTx organizations. Seeking to replace its traditional paper lab notebooks with an integrated data management framework, CTx selected the E-WorkBook Suite to simplify the capture, analysis, storage and retrieval of research data. Because the E-WorkBook Suite can integrate data into one location accessible throughout the organization, CTx expects to see efficiency gains in terms of project workflow improvements and protection of IP and patent information.